Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Virtual Congress 2020

Pfizer Oncology - RWE and me: Multidisciplinary views on real-world evidence (RWE) in oncology

The regulator perspective: RWE and real-world data (RWD) in drug approvals and label expansions

Date

14 Sep 2020

Session

Pfizer Oncology - RWE and me: Multidisciplinary views on real-world evidence (RWE) in oncology

Presenters

Jorge Camarero

Authors

J. Camarero

Author affiliations

  • Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), 28022 - Madrid/ES

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Welcome and introduction

Presenter: George Demetri

Session: Pfizer Oncology - RWE and me: Multidisciplinary views on real-world evidence (RWE) in oncology

Resources:

Webcast

Panel discussion

Presenter: George Demetri, Jorge Camarero, Oriol Solà-Morales, Renate Haidinger

Session: Pfizer Oncology - RWE and me: Multidisciplinary views on real-world evidence (RWE) in oncology

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.